Prognostic / Predictive Trials

Breathomics as a Predictor of Immunotherapy Response

Background: Immunotherapy is a common treatment for patients with advanced kidney cancer. This includes drugs that you may have heard of, such as Ipilimumab (Yervoy®) or Nivolumab (Opdivo®), which work by reactivating the body’s immune response to destroy cancer cells. Determining which patients will respond positively to...

Kidney Cancer Canada